Neurent Medical raises €62.5M Series C round
11 February 2026· Galway, Ireland· health, medtech, medical_devices, b2b, software_hardware
The funding will drive commercial expansion, broaden clinical evidence, and advance its product and indication pipeline to bring NEUROMARK to patients and physicians.
Investors
LeadMVM Partners
Also participating
Sofinnova PartnersEnterprise IrelandAtlantic BridgeEQT Life SciencesFountain Healthcare Partners
About Neurent Medical
Stage
Series C
Headquarters
Galway, Ireland
Founded
2015
Team Size
21–50
Sectors
healthmedtechmedical_devicesb2bsoftware_hardware